Results 11 to 20 of about 88,465 (244)

ACE inhibitors

Cardiovascular Drugs and Therapy, 1993
There are chemical differences among angiotensin-converting enzyme (ACE) inhibitors that profoundly influence the pharmacokinetics and dynamics of different drugs. Differences in potency, affinity, and duration of action can be readily identified.
  +9 more sources

Conformational changes of blood ACE in chronic uremia. [PDF]

PLoS ONE, 2012
BACKGROUND: The pattern of binding of monoclonal antibodies (mAbs) to 16 epitopes on human angiotensin I-converting enzyme (ACE) comprise a conformational ACE fingerprint and is a sensitive marker of subtle protein conformational changes.
Maxim N Petrov, Valery Y Shilo, Alexandr V Tarasov, David E Schwartz, Joe G N Garcia, Olga A Kost, Sergei M Danilov   +6 more
doaj   +1 more source

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy

Chronic Diseases and Translational Medicine, 2020
Introduction: Tripterygium glycosides (TGs) have been widely used in China to treat diabetic nephropathy (DN); however, proof of their use is scarce. The present study aimed to evaluate the effectiveness and safety of adding TGs to angiotensin-converting
Jin-Ying Fang, Yue Yang, Zheng Zhang, Shi-Min Jiang, Tian-Yu Yu, Wen-Ge Li   +5 more
doaj   +1 more source

Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Despite its clinical significance, the risk of severe infection requiring hospitalization among outpatients with severe acute respiratory syndrome coronavirus 2 infection who receive angiotensin‐converting enzyme (ACE) inhibitors and ...
Rohan Khera, Callahan Clark, Yuan Lu, Yinglong Guo, Sheng Ren, Brandon Truax, Erica S. Spatz, Karthik Murugiah, Zhenqiu Lin, Saad B. Omer, Deneen Vojta, Harlan M. Krumholz   +11 more
doaj   +1 more source

Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers

OncoImmunology, 2020
Angiotensin-converting enzyme (ACE) inhibitors are frequently used to treat hypertension and congestive heart failure. Preclinical data show that ACE plays a role on both innate and adaptive immune responses. Since interactions between ACE inhibitors and
Soleine Medjebar, Caroline Truntzer, Anaïs Perrichet, Emeric Limagne, Jean-David Fumet, Corentin Richard, Arielle Elkrief, Bertrand Routy, Cédric Rébé, François Ghiringhelli   +9 more
doaj   +1 more source

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis [PDF]

The Korean Journal of Internal Medicine, 2021
Background/Aims Inhibitors of the renin-angiotensin system, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), reportedly have anti-inflammatory effects.
Hyun Woo Lee, Jae Kyung Suh, Eunjin Jang, Sang-Min Lee   +3 more
doaj   +1 more source

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION

Рациональная фармакотерапия в кардиологии, 2015
Data of large-scale research that shows comprehensive abilities of an angiotensin converting enzyme (ACE) inhibitors in clinical practice were represented.
D. B. Nebieridze, A. S. Safaryan
doaj   +3 more sources

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2

ESC Heart Failure, 2021
Aims Concern has been raised that treatment with angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers may increase the expression of angiotensin‐converting enzyme 2 (ACE2), which acts as the entry receptor for SARS‐CoV‐2, and lead ...
Tobias Zimmermann, Joan Elias Walter, Pedro Lopez‐Ayala, Ivo Strebel, Melissa Amrein, Michael Koechlin, Ursina Honegger, Christian Mueller, BASEL VIII Investigators   +8 more
doaj   +1 more source

Unrecognized recurrent perioperative angioedema requiring intubation in a patient taking long-term angiotensin-converting enzyme inhibitor therapy

Otolaryngology Case Reports, 2022
Introduction: Angiotensin converting enzyme (ACE) inhibitors are a leading class of antihypertensives, which are a well-documented cause of angioedema related to prescription drugs. The purpose of this report is to highlight the importance of recognition
Christopher Wojcik, Brian Farrell
doaj   +1 more source

The use of angiotensin-converting enzyme inhibitors in general medicine

South African Family Practice, 2012
Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs commonly used in the management of hypertension, congestive heart failure, cerebrovascular disease, stable coronary heart disease and diabetes-associated nephropathy.
M.L.I. Mashitisho
doaj   +1 more source